Vor Bio to Participate in Upcoming Investor Conferences
BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:
TD Cowen Virtual Immunology & Inflammation Summit
Fireside Chat: Wednesday, November 12, 2025, at 2:30pm ET
8th Annual Evercore Healthcare Conference
Fireside Chat: Tuesday, December 2, 2025, 3:00pm ET
Location: Miami, FL
A live webcast and archived replay of the fireside chats will be available on the investors section of www.vorbio.com.
About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.
Media & Investor Contacts:
Carl Mauch
cmauch@vorbio.com
Sarah Spencer
investors@vorbio.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
